Outsourcing Outlook

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-04-02-2002, Volume 26, Issue 4

The author discusses the current soft demand and excess capacity in the contract-manufacturing market of small molecule actives and intermediates.

Related Content:

Bio/Pharma BusinessOutsourcingContract Manufacturing, GeneralPharmaceutical Technology-04-02-2002
Pharma 4.0: What are Industry Leaders Prioritizing in the Modernization of Pharmaceutical Manufacturing?
INTERPHEX 2025: How Functional Labeling Can Protect Parentals in Vials and Syringes
WMFTS’ BioPure to Showcase Single-Use Bioclamp with Refined Manufacturing at INTERPHEX 2025